Abstract
Legal liability concerns rank among the top organizational barriers to telemedicine adoption. Such concerns extend to medication-assisted treatment for opioid use disorders and to clinical use of controlled substances in general. These concerns stem from the complex web of federal and state regulations that govern teleprescribing of controlled substances. Existing health law literature on this topic has in large measure summarized regulations and exceptions under the Ryan Haight Act Online Pharmacy Consumer Protection Act (Ryan Haight Act) or categorized state telemedicine laws by nature and breadth of requirement. However, flowcharts can aid in the cognition, understanding, and evaluation of complex legal knowledge. This study analyzed the Ryan Haight Act, state administrative code, and published telemedicine guidelines using a multimethod qualitative approach. Legal analysis identified the structure and key language of federal statute through examination of sentence structure, logical connectors, punctuation, and key terms and language. Subsequently, Ryan Haight Act and state regulatory compliance flowcharts were developed using an adapted version of the six-stage process described by the American Society for Quality (ASQ). The creation of flowcharts proceeded in an iterative manner, and an interdisciplinary workgroup of subject matter experts reviewed the results for logic, clarity, cohesion, completion, and accuracy. Regulatory compliance flowcharts for teleprescribing of controlled substances may provide practitioners, educators, and advocates a tool for telemedicine risk management, competency-based education, and policy development.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
21 C.F.R. § 1307 C.F.R (2011).
42 C.F.R. § 410 C.F.R (2011).
50-state survey (2019). Establishment of a patient-physician relationship via telemedicine. Retrieved from American Medical Association Website: https://www.ama-assn.org/system/files/2018-10/ama-chart-telemedicine-patient-physician-relationship.pdf.
Andreae, M. H., Rhodes, E., Bourgoise, T., Carter, G. M., White, R. S., Indyk, D., Sacks, H., & Rhodes, R. (2016). An ethical exploration of barriers to research on controlled drugs. American Journal of Bioethics, 16(4), 36–47. https://doi.org/10.1080/15265161.2016.1145282.
Anguera, M. T., Villaseñor, A., Losada, J., Sanchez-Algarra, P., & Onwuegbuzie, A. J. (2018). A Revisiting the difference between mixed methods and multimethods: Is it all in the name? Quality & Quantity, 52(6), 2757–2770. https://doi.org/10.1007/s11135-018-0700-2.
ATA Sends Recommendations regarding the Special Registration Process for Telehealth under the Ryan Haight Act to the DEA (2019). Retrieved from American Telemedicine Association Website: https://thesource.americantelemed.org/blogs/jessica-washington/2019/01/12/ata-sends-recommendations-regarding-the-special-re.
Blake, V. (2013). Fighting prescription drug abuse with federal and state law. Virtual Mentor, 15(5), 443–448. https://doi.org/10.1001/virtualmentor.2013.15.5.hlaw1-1305.
Brooks, E., Turvey, C., & Augusterfer, E. F. (2013). Provider barriers to telemental health: Obstacles overcome, obstacles remaining. Telemed e-Health, 19(6), 433–437. https://doi.org/10.1089/tmj.2013.0068.
Brunschwig, C. (2014). On visual law: Visual legal communication practices and their scholarly exploration. In E. Schweighofer et al. (Eds.), Zeichen und Zauber des Rechts: Festschrift für Friedrich Lachmayer (pp. 899–933). Bern: Editions Weblaw. https://doi.org/10.5167/uzh-94333.
Brushwood, D. B. (2005). Defining “legitimate medical purpose”. American Journal of Health-System Pharmacy, 62(3), 306–308. https://doi.org/10.1093/ajhp/62.3.306.
Caudill, R. L. (2018). Update on developments with Ryan Haight and online prescribing. Retrieved from American Psychiatric Association Website: https://www.psychiatry.org/psychiatrists/practice/telepsychiatry/blog/update-on-developments-with-ryan-haight-and-online-prescribing.
Caudill, R. L., & Sager, Z. (2015). Institutionally based videoconferencing. International Review of Psychiatry, 27(6), 496–503. https://doi.org/10.3109/09540261.2015.1085369.
Colligan, L., Anderson, J. E., Potts, H. W. W., & Berman, J. (2010). Does the process map influence the outcome of quality improvement work? A comparison of a sequential flow diagram and a hierarchical task analysis diagram. BMC Health Services Research, 10(7), 1–9. https://doi.org/10.1186/1472-6963-10-7.
Continuing Medical Education: Board by Board Overview (2019). Retrieved from Federation of State Medical Boards Website: http://www.fsmb.org/siteassets/advocacy/key-issues/continuing-medical-education-by-state.pdf.
Controlled Substances Act of 1970, 21 U.S.C. §§ 802–831 (1970).
Cross State Licensing (2019). Retrieved from Center for Connected Health Policy Website: https://www.cchpca.org/telehealth-policy/cross-state-licensing.
Dineen, K. K., & DuBois, J. M. (2016). Between a rock and a hard place: Can physicians prescribe opioids to treat pain adequately while avoiding legal sanction? American Journal of Law & Medicine, 42(1), 7–52. https://doi.org/10.1177/0098858816644712.
Dunham, C.C.I. (2018). Will Federal special registration exception preempt more stringent state rules on remote prescribing of controlled substances? Retrieved from TechHealth perspectives website: https://www.techhealthperspectives.com/2018/08/14/will-federal-special-registration-exception-preempt-more-stringent-state-rules-on-remote-prescribing-of-controlled-substances/.
Edersheim, J. G., & Stern, T. A. (2009). Liability associated with prescribing medications. Primary Care Companion to The Journal of Clinical Psychiatry, 11(3), 115–119 Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708008/?report=reader.
Field, R. I. (2008). Why is health care regulation so complex? Pharmacy and Therapeutics, 33(10), 607–608 Retrieved from https://www.ptcommunity.com/system/files/pdf/ptj3310607.pdf.
Fleisher, L.D., & Dechene, J.C. (2013). Telemedicine and E-health law. Law Journal Seminars Press.
Gabay, M. (2013). Federal Controlled Substances act: Controlled substances prescriptions. Hospital Pharmacy, 48(8), 644–645. https://doi.org/10.1310/hpj4808-644.
Gabay, M. (2014). Federal Controlled Substances act: Dispensing requirements, electronic prescriptions, and fraudulent prescriptions. Hospital Pharmacy, 49(3), 244–246. https://doi.org/10.1310/hpj4903-244.
Garcia, A. M. (2013). State laws regulating prescribing of controlled substances: Balancing the public health problems of chronic pain and prescription painkiller abuse and overdose. Journal of Law, Medicine & Ethics, 41(s1), 42–45. https://doi.org/10.1111/jlme.12037.
Heslin, K., Elixhauser, A., & Steiner, C. (2012). Hospitalizations involving mental and substance use disorders among adults. Healthcare Cost and Utilization Project. Retrieved from https://www.hcup-us.ahrq.gov/reports/statbriefs/sb191-Hospitalization-Mental-Substance-Use-Disorders-2012.pdf.
Hess, G. F., & Friedland, S. (1999). Techniques for teaching law. Durham: Carolina Academic Press.
Hilty, D. M., Yellowlees, P. M., Parrish, M. B., & Chan, S. (2015a). Telepsychiatry: Effective, evidence-based, and at a tipping point in health care delivery? Psychiatric Clinics of North America, 38(3), 559–592. https://doi.org/10.1016/j.psc.2015.05.006.
Hilty, D. M., Crawford, A., Teshima, J., Chan, S., Sunderji, N., Yellowlees, P. M., Kramer, G., O'Neill, P., Fore, C., Luo, J., & Li, S.-T. (2015b). A framework for telepsychiatric training and e-health: Competency-based education, evaluation and implications. International Review of Psychiatry, 27(6), 569–592. https://doi.org/10.3109/09540261.2015.1091292.
Hilty, D. M., Maheu, M. M., Drude, K. P., & Hertlein, K. M. (2018). The need to implement and evaluate telehealth competency frameworks to ensure quality care across behavioral health professions. Academic Psychiatry, 42(6), 818–824. https://doi.org/10.1007/s40596-018-0992-5.
Hodge, J. G., & Corbett, A. (2016). Legal preemption and the prevention of chronic conditions. Preventing Chronic Disease, 13(6), 13. https://doi.org/10.5888/pcd13.160121.
Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (2009). Final Rule, 74 C.F.R. §§ 1300–1306.
Improvement Leaders’ Guide: Process mapping, analysis and redesign (2005). Retrieved from National Health Service England Website: https://www.england.nhs.uk/improvement-hub/wp-content/uploads/sites/44/2017/11/ILG-1.2-Process-Mapping-Analysis-and-Redesign.pdf.
Interstate Medical Licensure Compact (2015). Retrieved from Interstate Medical Licensure Compact Website: https://imlcc.org/wp-content/uploads/2018/04/IMLC-Compact-Law.pdf.
Interstate Medical Licensure Compact (2019). Retrieved from Interstate Medical Licensure Compact Website: https://imlcc.org.
Kramer, G. M., Mishkind, M. C., Luxton, D. D., & Shore, J. H. (2013). 6 - Managing risk and protecting privacy in Telemental health: An overview of legal, regulatory, and risk-management issues. In K. Myers & C. L. Turvey (Eds.), Telemental health (pp. 83–107). Oxford: Elsevier.
Maheu, M. M., Drude, K. P., Hertlein, K. M., & Hilty, D. M. (2018). A framework of interprofessional telebehavioral health competencies: Implementation and challenges moving forward. Academic Psychiatry, 42(6), 825–833. https://doi.org/10.1007/s40596-018-0988-1.
Mandated Use of State Prescription Drug Monitoring Programs (PMPS) (2017) Highlights of key state requirements. Retrieved from National Alliance for Model State Drug Laws Website: https://namsdl.org/wp-content/uploads/Mandated-Use-of-State-Prescription-Drug-Monitoring-Programs-PMPs-Highlights-of-Key-State-Requirements.pdf.
Mandatory Prescriber Education Guidance (2018). Retrieved from New York Department of Public Health Website: https://www.health.ny.gov/professionals/narcotic/docs/mandatory_education_guidance.pdf.
Margolis, C. Z. (1983). Uses of clinical algorithms. JAMA, 249(5), 627–632. https://doi.org/10.1001/jama.1983.03330290049028.
Merriam, J. (2017). Preemption as a consistency doctrine. William & Mary Bill of Rights Journal, 25(3), 981–1045 Retrieved from https://scholarship.law.wm.edu/wmborj/vol25/iss3/10.
Mikos, R. A. (2013). Preemption under the Controlled Substances Act. Journal of Health Care Law & Policy, 16(1), 13–23 Retrieved from http://digitalcommons.law.umaryland.edu/jhclp.
Model policy for the use of controlled substances for the treatment of pain (2005). Journal of Pain & Palliative Care Pharmacotherapy, 19(2), 73–78. https://doi.org/10.1080/J354v19n02_14
National Policy: Online Prescribing (2018). Retrieved from Center for Connected Health Policy Website: https://www.cchpca.org/telehealth-policy/online-prescribing.
Neimark, G. (2009). Boundary violation. Journal of the American Academy of Psychiatry and the Law Online, 37, 95–97 Retrieved from http://jaapl.org/content/37/1/95/tab-article-info.
Opioid Prescribing Courses for Health Care Providers (2019). Retrieved from Substance Abuse and Mental Health Services Administration Website: https://www.samhsa.gov/medication-assisted-treatment/training-resources/opioid-courses.
Passera, S. (2018). Flowcharts, Swimlanes, and timelines: Alternatives to prose in communicating legal–bureaucratic instructions to civil servants. Journal of Business and Technical Communication, 32(2), 229–272. https://doi.org/10.1177/1050651917746459.
PDMP TTAC (2019). Retrieved from Prescription Drug Monitoring Program Training and Technical Assistance Center Website: http://www.pdmpassist.org/content/prescription-drug-monitoring-frequently-asked-questions-faq.
Pettersson, R. (2010). Information design–principles and guidelines. Journal of VIsual Literacy, 29(2), 167–182. https://doi.org/10.1080/23796529.2010.11674679.
Porterfield, A., Engelbert, K., & Coustasse, A. (2014). Electronic prescribing: Improving the efficiency and accuracy of prescribing in the ambulatory care setting. Perspectives in Health Information Management, 11(Spring). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995494/.
Preemption (2009). What it is, how it works, and why it matters for public health. Retrieved from National Policy and Legal Analysis Network to Prevent Childhood Obesity Website: https://www.publichealthlawcenter.org/sites/default/files/resources/nplan-memo-preemption-2009.pdf.
Prescription Drug Monitoring Programs (2019). Retrieved from National Alliance for Model State Drug Laws Website: http://www.namsdl.org/prescription-monitoring-programs.cfm.
Prescription Drug Monitoring Programs: A Guide for Healthcare Providers (2017). Retrieved from Substance Abuse and Mental Health Services Administration Website: https://store.samhsa.gov/system/files/sma16-4997.pdf.
Ramsey, M. D. (2013). The supremacy clause, original meaning, and modern law. Ohio State Law Journal, 74, 559–618 Retrieved from https://kb.osu.edu/bitstream/handle/1811/71593/OSLJ_V74N4_0559.pdf.
Richard, J., & Reidenberg, M. M. (2005). The risk of disciplinary action by state medical boards against physicians prescribing opioids. Journal of Pain and Symptom Management, 29(2), 206–212. https://doi.org/10.1016/j.jpainsymman.2004.05.009.
Robin, L. (2017). State CME and PDMP Overview. Retrieved from Food and Drug Administration website: https://www.fda.gov/downloads/Drugs/NewsEvents/UCM558395.pdf.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (2008). 21, U.S.C. §§ 1–4.
Scott Kruse, C., Karem, P., Shifflett, K., Vegi, L., Ravi, K., & Brooks, M. (2018). Evaluating barriers to adopting telemedicine worldwide: A systematic review. Journal of Telemedicine and Telecare, 24(1), 4–12. https://doi.org/10.1177/1357633X16674087.
Shiffman, R. N. (1997). Representation of clinical practice guidelines in conventional and augmented decision tables. Journal of the American Medical Informatics Association, 4(5), 382–393. https://doi.org/10.1136/jamia.1997.0040382.
Shore, J. H., Yellowlees, P., Caudill, R., Johnston, B., Turvey, C., Mishkind, M., Krupinski, E., Myers, K., Shore, P., Kaftarian, E., & Hilty, D. (2018). Best practices in videoconferencing-based telemental health April 2018. Telemedicine and e-Health, 24(11), 827–832. https://doi.org/10.1089/tmj.2018.0237.
State Profiles (2019). Retrieved from National Association of State Controlled Substances Authorities Website: http://www.nascsa.org/stateprofiles.htm.
State Telehealth Laws and Reimbursement Policies (2017). A comprehensive scan of the 50 states and the District of Columbia. Retrieved from http://www.cchpca.org/sites/default/files/resources/Telehealth%20Laws%20and%20Policies%20Report%20FINAL%20Fall%202017%20PASSWORD.pdf.
Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 (2018). H.R. 6, 115th Cong.
Tague, N. R. (2005). The Quality Toolbox, Second Edition. Milwaukee: ASQ Quality Press.
Telemedicine Policies: Board by Board Overview (2018). Key issues by state. Retrieved from Federation of State Medical Boards Website: http://www.fsmb.org/siteassets/advocacy/key-issues/telemedicine_policies_by_state.pdf.
Thomas, L., & Capistrant, G. (2017). State telemedicine gaps analysis: Physician practice standards & licensure. Retrieved from https://utn.org/resources/downloads/50-state-telemedicine-gaps-analysis-physician-practice-standards-licensure.pdf
Torous, J., Chan, S., Luo, J., Boland, R., & Hilty, D. (2017). Clinical informatics in psychiatric training: Preparing today’s trainees for the already present future. Academic Psychiatry, 42, 694–697. https://doi.org/10.1007/s40596-017-0811-4.
Virzi, R. A. (1992). Refining the test phase of usability evaluation: How many subjects is enough? Human Factors, 34(4), 457–468. https://doi.org/10.1177/001872089203400407.
Webley, L. (2010). Qualitative approaches to empirical legal research. In P. Cane & H. M. Kritzer (Eds.), The Oxford handbook of empirical legal research (pp. 927–950). Oxford: Oxford University Press.
Yang, Y. T., Larochelle, M. R., & Haffajee, R. L. (2017). Managing increasing liability risks related to opioid prescribing. American Journal of Medicine, 130(3), 249–250. https://doi.org/10.1016/j.amjmed.2016.08.041.
Yang, Y. T., Weintraub, E., & Haffajee, R. L. (2018). Telemedicine’s role in addressing the opioid epidemic. Mayo Clinic Proceedings, 93(9), 1177–1180. https://doi.org/10.1016/j.mayocp.2018.07.001.
Acknowledgements
The authors would like to acknowledge the American Telemedicine Association and Telemental Health Special Interest Group, American Psychiatric Association and Telepsychiatry Committee, and Drug Enforcement Administration.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lingam, H.A., Caudill, R.L. Teleprescribing Controlled Substances: Flowchart Analysis of the Ryan Haight Act and State Telemedicine Laws. J. technol. behav. sci. 4, 346–359 (2019). https://doi.org/10.1007/s41347-019-00100-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41347-019-00100-2